Literature DB >> 16181449

Topical tacrolimus and pimecrolimus and the risk of cancer: how much cause for concern?

A D Ormerod.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16181449     DOI： 10.1111/j.1365-2133.2005.06899.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  16 in total

1.  Network pharmacology and molecular docking-based prediction of active compounds and mechanisms of action of Cnidii Fructus in treating atopic dermatitis.

Authors:  Shakeel Ahmad Khan; Ying Wu; Amy Sze-Man Li; Xiu-Qiong Fu; Zhi-Ling Yu
Journal:  BMC Complement Med Ther       Date:  2022-10-19

Review 2.  Topical calcineurin inhibitors in pediatric atopic dermatitis: a critical analysis of current issues.

Authors:  Seth J Orlow
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

Review 3.  New agents for treating dry eye syndrome.

Authors:  Simon E Skalicky; Con Petsoglou; Avinash Gurbaxani; Clare L Fraser; Peter McCluskey
Journal:  Curr Allergy Asthma Rep       Date:  2013-06       Impact factor: 4.806

Review 4.  The US FDA 'black box' warning for topical calcineurin inhibitors: an ongoing controversy.

Authors:  Johannes Ring; Matthias Möhrenschlager; Verena Henkel
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

5.  Treating atopic dermatitis: safety, efficacy, and patient acceptability of a ceramide hyaluronic acid emollient foam.

Authors:  Omar Pacha; Adelaide A Hebert
Journal:  Clin Cosmet Investig Dermatol       Date:  2012-05-07

6.  Treating ocular surface disease: new agents in development.

Authors:  Ahmad M Fahmy; David R Hardten
Journal:  Clin Ophthalmol       Date:  2011-04-14

7.  Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomes.

Authors:  H Mawardi; S Elad; M E Correa; K Stevenson; S-B Woo; S Almazrooa; R Haddad; J H Antin; R Soiffer; N Treister
Journal:  Bone Marrow Transplant       Date:  2011-04-04       Impact factor: 5.483

8.  FKBP51 protects 661w cell culture from staurosporine-induced apoptosis.

Authors:  Donald Raymond Daudt; Thomas Yorio
Journal:  Mol Vis       Date:  2011-05-04       Impact factor: 2.367

Review 9.  Photocarcinogenicity of selected topically applied dermatological drugs: calcineurin inhibitors, corticosteroids, and vitamin D analogs.

Authors:  Catharina M Lerche; Hans Christian Wulf
Journal:  Dermatol Reports       Date:  2010-09-14

Review 10.  Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis.

Authors:  Elaine C Siegfried; Jennifer C Jaworski; Jennifer D Kaiser; Adelaide A Hebert
Journal:  BMC Pediatr       Date:  2016-06-07       Impact factor: 2.125
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.